These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 31153778
21. Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review. Ahmad J, Grimes N, Farid S, Morris-Stiff G. Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):474-81. PubMed ID: 25308357 [Abstract] [Full Text] [Related]
22. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer? Dogan M, Algin E, Guven ZT, Baykara M, Kos TF, Bal O, Zengin N. Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926 [Abstract] [Full Text] [Related]
23. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer. Liu Z, Jin K, Guo M, Long J, Liu L, Liu C, Xu J, Ni Q, Luo G, Yu X. Ann Surg Oncol; 2017 Feb; 24(2):561-568. PubMed ID: 27650825 [Abstract] [Full Text] [Related]
24. Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter. Yamada S, Fujii T, Yabusaki N, Murotani K, Iwata N, Kanda M, Tanaka C, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Medicine (Baltimore); 2016 May; 95(18):e3582. PubMed ID: 27149487 [Abstract] [Full Text] [Related]
25. Preoperative Neutrophil-Lymphocyte and Lymphocyte-Monocyte Ratios Reflect Immune Cell Population Rearrangement in Resectable Pancreatic Cancer. Sierzega M, Lenart M, Rutkowska M, Surman M, Mytar B, Matyja A, Siedlar M, Kulig J. Ann Surg Oncol; 2017 Mar; 24(3):808-815. PubMed ID: 27770341 [Abstract] [Full Text] [Related]
26. Pretherapy neutrophil to lymphocyte ratio and platelet to lymphocyte ratio do not predict survival in resectable pancreatic cancer. Chawla A, Huang TL, Ibrahim AM, Hardacre JM, Siegel C, Ammori JB. HPB (Oxford); 2018 May; 20(5):398-404. PubMed ID: 29221789 [Abstract] [Full Text] [Related]
27. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer. Sun X, Liu X, Liu J, Chen S, Xu D, Li W, Zhan Y, Li Y, Chen Y, Zhou Z. Chin J Cancer; 2016 Jun 24; 35(1):57. PubMed ID: 27342313 [Abstract] [Full Text] [Related]
28. Lymphocyte-to-Monocyte Ratio and Prognostic Nutritional Index Predict Poor Prognosis in Patients on Chemotherapy for Unresectable Pancreatic Cancer. Shimizu T, Taniguchi K, Asakuma M, Tomioka A, Inoue Y, Komeda K, Hirokawa F, Uchiyama K. Anticancer Res; 2019 Apr 24; 39(4):2169-2176. PubMed ID: 30952764 [Abstract] [Full Text] [Related]
29. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment. Kubota K, Ito R, Narita N, Tanaka Y, Furudate K, Akiyama N, Chih CH, Komatsu S, Kobayashi W. BMC Cancer; 2022 Apr 07; 22(1):368. PubMed ID: 35392843 [Abstract] [Full Text] [Related]
30. Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection. Tokunaga R, Sakamoto Y, Nakagawa S, Izumi D, Kosumi K, Taki K, Higashi T, Miyata T, Miyamoto Y, Yoshida N, Baba H. Int J Clin Oncol; 2017 Aug 07; 22(4):740-748. PubMed ID: 28213742 [Abstract] [Full Text] [Related]
31. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer. Toyokawa T, Muguruma K, Yoshii M, Tamura T, Sakurai K, Kubo N, Tanaka H, Lee S, Yashiro M, Ohira M. BMC Cancer; 2020 Jun 03; 20(1):517. PubMed ID: 32493247 [Abstract] [Full Text] [Related]
33. Clinical significance of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio and prognostic nutritional index in low-risk differentiated thyroid carcinoma. Offi C, Romano RM, Cangiano A, Candela G, Docimo G. Acta Otorhinolaryngol Ital; 2021 Feb 03; 41(1):31-38. PubMed ID: 33746220 [Abstract] [Full Text] [Related]
34. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer. Iwai N, Okuda T, Sakagami J, Harada T, Ohara T, Taniguchi M, Sakai H, Oka K, Hara T, Tsuji T, Komaki T, Kagawa K, Yasuda H, Naito Y, Itoh Y. Sci Rep; 2020 Oct 30; 10(1):18758. PubMed ID: 33127996 [Abstract] [Full Text] [Related]
36. The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma. Onoe S, Maeda A, Takayama Y, Fukami Y, Takahashi T, Uji M, Kaneoka Y. Med Princ Pract; 2019 Oct 30; 28(6):517-525. PubMed ID: 31104057 [Abstract] [Full Text] [Related]
40. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Sanjay P, de Figueiredo RS, Leaver H, Ogston S, Kulli C, Polignano FM, Tait IS. JOP; 2012 Mar 10; 13(2):199-204. PubMed ID: 22406601 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]